* NextCure Inc NXTC.OQ reported a quarterly adjusted loss
of 65 cents per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 61 cents per share.
* Reported revenue was zero; analysts expected zero.
* NextCure Inc's reported EPS for the quarter was a loss of 65
cents.
* The mean earnings estimate of analysts had risen by about 2.6%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* NextCure Inc shares had fallen by 6.4% this quarter and
lost 31.0% so far this year.
* The company reported a quarterly loss of $17.99 million.
* Wall Street's median 12-month price target for NextCure Inc is
$17.00
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
This summary was machine generated August 6 at 06:11 a.m. All
figures in US dollars unless otherwise stated